73
Participants
Start Date
May 29, 2019
Primary Completion Date
August 10, 2021
Study Completion Date
April 3, 2026
Berzosertib
Given IV
Carboplatin
Given IV
Docetaxel
Given IV
Laboratory Biomarker Analysis
Correlative studies
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
VCU Massey Comprehensive Cancer Center, Richmond
Ohio State University Comprehensive Cancer Center, Columbus
Wayne State University/Karmanos Cancer Institute, Detroit
UCHealth University of Colorado Hospital, Aurora
City of Hope Comprehensive Cancer Center, Duarte
UC San Diego Moores Cancer Center, La Jolla
University of California Davis Comprehensive Cancer Center, Sacramento
Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center - Guilford, Guilford
Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Smilow Cancer Center/Yale-New Haven Hospital, New Haven
Yale University, New Haven
Yale-New Haven Hospital North Haven Medical Center, North Haven
Smilow Cancer Hospital-Orange Care Center, Orange
Smilow Cancer Hospital-Torrington Care Center, Torrington
Smilow Cancer Hospital Care Center-Trumbull, Trumbull
Smilow Cancer Hospital-Waterbury Care Center, Waterbury
Smilow Cancer Hospital Care Center - Waterford, Waterford
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Rutgers Cancer Institute of New Jersey, New Brunswick
National Cancer Institute (NCI)
NIH